After an extended vacay, I'm back. Blimey, Painchek is goddam slow at commercializing.
Sad to say I messed up with the investment in this company, but holding on due to catalysts like FDA could turn things around. In saying that, I would much rather have them be bought out by ResMed, like what happened with Resapp and Pfizer.
$200M market cap if it ever gets there is where I would sell. Management is way too slow in producing results. The revenues are plateauing; funnily enough, Painchek is approaching the total addressable market in Australia ~ $4M p.a. Replicating this internationally requires more resources which they currently don't have.
After an extended vacay, I'm back. Blimey, Painchek is goddam...
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $55.61M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.7¢ | 3.4¢ | $45.39K | 1.278M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 497311 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 254838 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| PCK (ASX) Chart |